AI meets immunology
– enabling discoveries that redefine diagnostics and therapeutic development.
Our Platform
MyImmune’s AI-powered platform leverages adaptive immune networks to decode
the immune system, transforming biological data into actionable insights
that accelerate diagnostics and therapeutic discovery.
As our platform evolves, its purpose becomes even more defined:
turning scientific insight into meaningful impact for patients.
Our Mission
Driven by a passion for innovation, MyImmune’s team works at the intersection
of AI and immunology to develop advanced diagnostics and therapies that improve
patient care.
To understand how our mission evolves into measurable progress,
we focus on the analytical framework guiding our platform.
Our Science
MyImmune’s approach to clustering BCR and TCR repertoire data, developed in Daron Standley’s lab at Osaka University, opens up new avenues for biomedical research.
Disease Detection
Leveraging adaptive immune receptor paratope networks, MyImmune’s platform
can achieve highly accurate detection of cancer, autoimmune, and infectious
diseases, while uncovering a reservoir of therapeutic immune cells in healthy
individuals, opening new possibilities for precision diagnostics and treatment.
Antibody Clustering
Using a novel clustering method based on CDR sequences, MyImmune’s platform
successfully identifies antigen-specific and neutralizing antibodies, offering
a powerful tool for MyImmune to accelerate the discovery of therapeutic
antibodies for diseases like cancer and autoimmune disorders.
Partnerships
Advancing our understanding of the immune system requires collaboration.
MyImmune combines advanced AI with deep immunology to enable earlier disease detection,
accelerate therapeutic discovery, and achieve more precise immune profiling.
We welcome partnerships with academic, clinical, and industry collaborators
who are interested in shaping this path together.
If you would like to explore a potential collaboration,
we invite you to leave a message and connect directly with our team.